Joan van den Bosch

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

The effects of 5-aza-2′-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromes

Joan van den Bosch, Michael Lübbert, Gregor Verhoef et al. · Leukemia Research · 2004 · 90 citations

Medicine, Hematology, Pharmacology +14

Real-World Outcomes of Radium-223 Dichloride for Metastatic Castration Resistant Prostate Cancer

M. Kuppen, Hans M. Westgeest, Maarten J. van der Doelen et al. · Future Oncology · 2020 · 42 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy

Siu W. Lam, Nienke M. Nota, Agnes Jager et al. · Clinical Cancer Research · 2016 · 28 citations

Medicine, Oncology, Pharmacology +17

Association Between Geriatric Assessment and Post-Chemotherapy Functional Status in Older Patients with Cancer

Hánah N. Rier, Marieke C. Meinardi, Joost van Rosmalen et al. · The Oncologist · 2022 · 17 citations · Full text

Medicine, Geriatric Medicine, Oncology +17